 |
California Law (Last Updated: March 4, 2014) |
 |
Health and Safety Code - HSC |
|
Division 106. PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT) |
|
Part 5.5. USE OF HUMAN CELLS |
|
Chapter 2. Procuring of Oocytes for Research |
Section 125330.
-
The following definitions shall apply to this chapter:
(a) "Assisted oocyte production" or "AOP" means surgical extraction of oocytes following pharmaceutically induced manipulation of oocyte production through the use of ovarian stimulation.
(b) "Oocyte" means a female egg or egg cell of a human female.
(c) "Subject" means any person undergoing AOP or any alternative method of ovarian retrieval for research or for the development of medical therapies, including those who would not meet the definition of "subject" under 45 C.F.R. 46.102.
(d) "Alternate method of oocyte retrieval" means a method of oocyte retrieval that does not involve the pharmaceutically induced manipulation of oocyte production.
(e) "Institutional review board" means a body established in accordance with federal regulations, including Part 46 (commencing with Section 46.101) o.